title: Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway.
authors.affiliation: Tisch Cancer Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Lu
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Dmitriy
authors.initials: D
authors.lastname: Berenzon
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Wang
authors.forename: Jiapeng
authors.initials: J
authors.lastname: Wang
authors.forename: John
authors.initials: J
authors.lastname: Mascarenhas
authors.forename: Mingjiang
authors.initials: M
authors.lastname: Xu
authors.forename: Ronald
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D018952:Antigens, CD34 / Q000276:immunology; D015153:Blotting, Western; D005434:Flow Cytometry; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D018952:Antigens, CD34; D016898:Interferon-alpha; D048051:p38 Mitogen-Activated Protein Kinases